Search
for
Sort by
Research 781–810 of 1000+
- Secreted Frizzled‐Related Protein 2 ( SFRP2 ) Induces Follistatin‐Like 1 ( FSTL1 ) to Regulate Dihydrotestosterone ( DHT )‐Induced Dermal Papilla Cell Mitochondrial Dysfunction and Senescence
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- The Wnt inhibitor, Dickkopf 4, is induced by canonical Wnt signaling during ectodermal appendage morphogenesis
- Role of janus kinase inhibitors in the treatment of alopecia areata
- LL-37 stimulates the functions of adipose-derived stromal/stem cells via early growth response 1 and the MAPK pathway
- Identification of sirtuin 1 as a promising therapeutic target for hypertrophic scars
- DHT deficiency perturbs the integrity of the rat seminiferous epithelium by disrupting tight and adherens junctions
- Nature-derived lignan compound VB-1 exerts hair growth-promoting effects by augmenting Wnt/β-catenin signaling in human dermal papilla cells
- Bikunin, a Serine Protease Inhibitor, is Present on the Cell Boundary of Epidermis
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes
- Proliferative diabetic retinopathy as onset of type 1 diabetes
- Erlotinib-induced trichomegaly of eyelashes in lung cancer treatment: Epidermal growth factor receptor inhibitor side effect
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- 467 Novel selective phosphodiesterase inhibitors promote the adipogenic function of dermal fibroblasts: Implication to treat hair loss
- MP44-04 TRENDS IN 5-ALPHA REDUCTASE INHIBITOR USE BEFORE AND AFTER THE FOOD AND DRUG ADMINISTRATION SAFETY WARNING
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Commensal microbiome promotes hair follicle regeneration by inducing keratinocyte HIF-1α signaling and glutamine metabolism
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- Transgenic Kallikrein 14 Mice Display Major Hair Shaft Defects Associated with Desmoglein 3 and 4 Degradation, Abnormal Epidermal Differentiation, and IL-36 Signature
- Panax ginseng extract antagonizes the effect of DKK-1-induced catagen-ike changes of hair follicles
- <i>Eclipta prostrata</i> promotes the induction of anagen, sustains the anagen phase through regulation of FGF-7 and FGF-5
- Cepharanthine Inhibits Doxorubicin-Induced Cellular Senescence by Activating Autophagy via the mTOR Signaling Pathway
- GATA3 inhibits proliferation and induces expression of both early and late differentiation markers in keratinocytes of the human epidermis
- Camellia sinensis Seed Flavonoids Attenuate UVB-Induced Inflammation and UVA-Induced Photodamage via MAPK/NF-κB and AP-1 Pathways